Patient in limbo: the quest for a miracle and the stem cell scandal
When desperate hope meets an uncertain future, shocking things can happen even to the most seasoned observer: A patient in painful limbo relies on a promise of healing, only to find that the disease's grip tightens. Bad Batch: A Story of Stem Cells and the Search for a Miracle Cure, created by Wondery and led by esteemed journalist Laura Beil, takes us on a six-episode journey into one of the most glaring medical scandals in the U.S. The podcast, released in 2019, uncovers the story of stem cell treatments marketed under false pretenses by the company Liveyon, led by the charismatic John Kosolcharoen. The series is available both in an ad-supported version and ad-free through Wondery+ on platforms like Apple Podcasts and Spotify.
Regulatory gaps and manipulation: Beil's sharp revelations
From the first episode, Beil's sharp journalistic eye targets regulatory gaps and manipulation. She explores how Liveyon promoted experimental stem cell treatments, leading to serious infections among patients. The loopholes exploited in the system were as deep as the complexity of stem cell science itself. With a dramatic storytelling style combining thorough research and incisive interviews, listeners witness how the pharma industry can undermine its own ethical standards. However, the podcast has been criticized for focusing too much on Kosolcharoen's colorful personality at the expense of the systemic failures that allowed this scandal to occur.
Bad Batch's impact on public debate and policy
Following Bad Batch, the podcast has made a significant mark in both public debate and politics. The series reached a top ranking on Apple Podcasts and sparked a necessary discussion about the risks associated with inadequately regulated medical treatments. Beil's portrayal of the complex stem cell world provides both laypeople and professionals with a vital source of understanding. Meanwhile, U.S. authorities have faced increased pressure to tighten regulations on the stem cell industry, while patient organizations warn against dangerous treatment methods. Bad Batch stands as a significant contribution to the discussion on health ethics and consumer protection within journalism and corruption in the U.S.
Listen to Bad Batch now on